Krivosheeva Anna

Function: Endocrinologist.

Main specialty: Endocrinology.

Clinic: MEDSI Clinical Diagnostic Centre at Belorusskaya

Education: Peoples' Friendship University of Russia (RUDN University), 2012.

Diploma specialty: Therapy.

Professionals achievements and experience: conduct of practice-oriented “Education for patients with diabetes mellitus” events, MEDSI Group of Companies JSC, since 2015.

Residency: Russian Medical Academy of Postgraduate Education (RMAPE), 2014.

Fellowship: Russian Medical Academy of Continuing Professional Education (RMACPE), 2018.

Advanced training courses:

  • “Obesity. Comorbidity and the principles of effective treatment” course, 2013-2018.
  • “Planning and management of pregnancy in patients with endocrine disorders” course, 2014-2015, 2017.
  • “The current aspects of the pathogenesis, diagnosis, and treatment of breast diseases” course, 2016.
  • “The current algorithms of the diagnosis and treatment of hyperparathyroidism. An interdisciplinary approach” course, 2015., 2017.
  • “The management of postmenopausal women with endocrine disorders” course, 2016-2017.
  • “Planning and management of pregnancy in patients with endocrine disorders” course, 2016-2017.
  • “The endocrine aspects of contraception” course, 2015-2017.
  • “An educational course for patients with diabetes mellitus” course, 2017.
  • “The psychophysiology and psychiatric management of overweight patients” course, 2017.

Participation in seminars, conferences, professional associations:

  • Young Scientists’ Conference “Topical issues of endocrinology”, 2016-2018.
  • Participant of the All-Russian Conference with International Participation “Diabetes mellitus: macro- and microvascular complications", since 2017.
  • Participant of the All-Russian Conference with International Participation “Female and male reproductive health”, since 2016.
  • Participant of the Conference “Innovative technologies in endocrinology: the diagnosis and treatment of osteoporosis”, since 2016.
  • Participant of the Scientific and Educational Conference “Innovative technologies in endocrinology: the new opportunities in the diagnosis and treatment of neuroendocrine diseases”, since 2016.
  • Participant of the Research and Practice Forum “Interdisciplinary aspects of oncological endocrinology”, since 2015.
  • Participant of the Interdisciplinary Research and Practice Conference with International Participation “Obesity. Visible manifestations of covert risks”, since 2015.
  • Participant of the All-Russian Congress with CIS Participation “Innovative technologies in endocrinology”, since 2014.
  • Participant of the Moscow City Convention of Endocrinologists “The capital’s endocrinology”, since 2014.
  • Participant of the Interregional Conference “Algorithms of the diagnosis and treatment of endocrine disorders”, since 2014.
  • Participant of the Moscow Assembly “The capital’s health”, since 2014.
  • Participant of the All-Russian Diabetology Congress “Diabetes mellitus in the 21st century: the time to join efforts”, since 2013.
  • Participant of the Conference “Interdisciplinary and multifactorial management of type 2 diabetes mellitus”, since 2012.

Publications, articles: 
Author and co-author of over 10 publications:

  • “Rational drug therapy with DPP-4 inhibitors” chapter, “Type 2 diabetes mellitus. Problems and solutions” study guide, 2014 (in Russian).
  • “Insulin therapy” chapter, “Type 2 diabetes mellitus. Problems and solutions” study guide, 2015 (in Russian).
  • “Effects of sodium-glucose co-transporter 2 inhibitors on the efficacy of type 2 diabetes management. A clinical overview”, article in the Endocrinology: News, Opinions, Education journal, 2016 (in Russian).
  • “The role of the kidneys and transport proteins in the regulation of glucose homeostasis” chapter, “Type 2 diabetes mellitus. Problems and solutions” book, 2017 (in Russian).
  • “The Empa-Reg Outcome trial: prospects in the management of cardiovascular risks” chapter, “Type 2 diabetes mellitus. Problems and solutions” book, 2017 (in Russian).
  • “Insulin therapy strategies: from mere blood glucose reduction to simulation of physiological secretion” chapter, “Type 2 diabetes mellitus. Problems and solutions” book, 2017 (in Russian).
  • “Effects of a sodium-glucose co-transporter 2 inhibitor on the efficacy of type 2 diabetes management”, article in the Endocrinology: News, Opinions, Education journal, 2017 (in Russian).
  • “Optimal fixed low dose combination of glibenclamide and metformin”, article in the Endocrinology: News, Opinions, Education journal, 2017 (in Russian).
  • “Prevention of type 2 diabetes mellitus”, article in the Endocrinology: News, Opinions, Education journal, 2017 (in Russian).
  • “The role of Diabeton MR in the modern treatment of type 2 diabetes mellitus”, article in the Endocrinology: News, Opinions, Education journal, 2017 (in Russian).

List of procedures and operations performed:

  • Consultation of patients with endocrine disorders
  • Diagnosis and treatment of osteoporosis due to endocrine disorders
  • Continuous glucose monitoring system (CGMS) installation and data analysis
  • Treatment of the following diseases:
    • Type 1 and type 2 diabetes mellitus, complications of diabetes
    • Obesity
    • Thyroid and parathyroid disorders
    • Adrenal disorders
    • Pituitary disorders
    • Climacteric syndrome

Age-related androgen deficiency

Ask callback